BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24404129)

  • 1. A new method to improve the clinical evaluation of cystic fibrosis patients by mucus viscoelastic properties.
    Tomaiuolo G; Rusciano G; Caserta S; Carciati A; Carnovale V; Abete P; Sasso A; Guido S
    PLoS One; 2014; 9(1):e82297. PubMed ID: 24404129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W; Garrett H; Speert DP; King M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage.
    App EM; Kieselmann R; Reinhardt D; Lindemann H; Dasgupta B; King M; Brand P
    Chest; 1998 Jul; 114(1):171-7. PubMed ID: 9674466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of rheology and portable low-field NMR in cystic fibrosis patients.
    Abrami M; Maschio M; Conese M; Confalonieri M; Gerin F; Dapas B; Farra R; Adrover A; Torelli L; Ruaro B; Grassi G; Grassi M
    Respir Med; 2021; 189():106623. PubMed ID: 34624628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
    Shah PL; Scott SF; Knight RA; Marriott C; Ranasinha C; Hodson ME
    Thorax; 1996 Feb; 51(2):119-25. PubMed ID: 8711640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Fibrosis Sputum Rheology Correlates With Both Acute and Longitudinal Changes in Lung Function.
    Ma JT; Tang C; Kang L; Voynow JA; Rubin BK
    Chest; 2018 Aug; 154(2):370-377. PubMed ID: 29559310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis.
    Homnick DN; Marks JH; Rubin BK
    J Aerosol Med; 2007; 20(1):45-9. PubMed ID: 17388752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is cystic fibrosis mucus abnormal?
    King M
    Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
    Shibuya Y; Wills PJ; Cole PJ
    Respirology; 2003 Jun; 8(2):181-5. PubMed ID: 12753533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheological effects of hypertonic saline and sodium bicarbonate solutions on cystic fibrosis sputum in vitro.
    Budai-Szűcs M; Berkó S; Kovács A; Jaikumpun P; Ambrus R; Halász A; Szabó-Révész P; Csányi E; Zsembery Á
    BMC Pulm Med; 2021 Jul; 21(1):225. PubMed ID: 34253193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.
    Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S
    Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH.
    Hill DB; Long RF; Kissner WJ; Atieh E; Garbarine IC; Markovetz MR; Fontana NC; Christy M; Habibpour M; Tarran R; Forest MG; Boucher RC; Button B
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial.
    Radtke T; Böni L; Bohnacker P; Maggi-Beba M; Fischer P; Kriemler S; Benden C; Dressel H
    BMC Pulm Med; 2018 Jun; 18(1):99. PubMed ID: 29898704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease.
    Hill DB; Vasquez PA; Mellnik J; McKinley SA; Vose A; Mu F; Henderson AG; Donaldson SH; Alexis NE; Boucher RC; Forest MG
    PLoS One; 2014; 9(2):e87681. PubMed ID: 24558372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.
    Bush A; Payne D; Pike S; Jenkins G; Henke MO; Rubin BK
    Chest; 2006 Jan; 129(1):118-23. PubMed ID: 16424421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway mucus in cystic fibrosis.
    Puchelle E; Bajolet O; Abély M
    Paediatr Respir Rev; 2002 Jun; 3(2):115-9. PubMed ID: 12297057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Milroy S
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD006842. PubMed ID: 32352564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sputum oscillations and rhDNase in vitro: a combined approach to treat cystic fibrosis lung disease.
    Dasgupta B; Brown NE; King M
    Pediatr Pulmonol; 1998 Oct; 26(4):250-5. PubMed ID: 9811074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate.
    Stigliani M; Manniello MD; Zegarra-Moran O; Galietta L; Minicucci L; Casciaro R; Garofalo E; Incarnato L; Aquino RP; Del Gaudio P; Russo P
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):337-45. PubMed ID: 26741302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.